Clinical Nuclear Medicine

Skip Navigation LinksHome > April 2013 - Volume 38 - Issue 4 > Can 18F-FDG PET/CT Reliably Assess Response to Primary Treat...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31828165a8
Original Articles

Can 18F-FDG PET/CT Reliably Assess Response to Primary Treatment of Head and Neck Cancer?

Ul-Hassan, Fahim MBBS, MRCP*; Simo, Ricard FRCS; Guerrero-Urbano, Teresa PhD, FRCR; Oakley, Richard FDSRCS, FRCS; Jeannon, Jean-Pierre FRCS; Cook, Gary J.R. MD, FRCR

Collapse Box


Introduction: Where chemoradiotherapy or radiotherapy alone with curative intent is used as the primary treatment of locally advanced head and neck cancers, salvage surgery may offer a second chance of cure in the face of recurrent or residual disease. Early detection of recurrent or residual disease is therefore the key to facilitating timely and efficacious salvage surgery. CT and MRI can be difficult to interpret in the posttreatment neck. Functional imaging, such as 18F-FDG PET/CT, has the potential to improve restaging accuracy. The aim of our study was to assess the efficacy of 18F-FDG PET/CT performed 3 months following primary treatment of head and neck cancer.

Methods: We retrospectively reviewed 35 patients with head and neck squamous cell cancer (mean age, 61 years; 28 male patients) who underwent 18F-FDG PET/CT imaging at 3 months following primary treatment, which included chemoradiotherapy (n = 31) or radiotherapy alone (n = 4). Patient follow-up was available for at least 12 months (range, 12–48 months; median, 36 months). Scans were categorized as true positive, true negative, false positive, and false negative based on clinicoradiological follow-up and histology.

Results: Twenty patients had negative scans with no recurrence during the follow-up period, and 3 had false-negative scans with recurrent disease at 5, 8, and 12 months. Eleven patients had true-positive scans, confirmed histologically in all, and there was 1 false-positive scan giving a sensitivity of 79%, specificity of 96%, positive predictive value of 92%, negative predictive value of 87%, and overall accuracy of 89%.

Conclusions: 18F-FDG PET/CT is an accurate method for assessing response after primary locally advanced head and neck cancer treatment. Although false-positive scans are rare, a few patients will have a relapse after a negative scan, and so continued close follow-up is required.

© 2013 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.